Videos

This Bayer-sponsored symposium titled ‘Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)’ took place…

The world of sexual health and sexual medicine is rapidly growing with greater awareness on human sexuality, and the integration of novel technologies in healthcare practices.

On the final day of EAU22 in Amsterdam, experts stepped away from the action to present highlights in prostate cancer treatment from this year’s congress.

A real-life, severe case study of AIP by Professor Ulrich Stoelzel. Video developed and funded by Alnylam Pharmaceuticals

A real-life, severe case of AIP by Professor Jean-Charles Deybach, MD PhD. Video developed and funded by Alnylam Pharmaceuticals.

In this symposium, Prof. Georg Schett, Prof. Denis Poddubnyy Dr. Raj Sengupta and Prof. Maria-Antonietta D’Agostino discuss: Impact and…

Discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges…

*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)